Biotechnology Stocks I Performance Guide: Moderna, Inc. (MRNA)
MRNA has no dividends.
Table and Chart of MRNA Performance
See what a $1,000 investment in MRNA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| MRNA Returns | |
|---|---|
| Start Date | Jan-31-2019 |
| Start Price | $16.60 |
| End Date | May-07-2024 |
| End Price | $121.07 |
| # Prices | 65 |
| Min Date | Jul-31-2019 |
| Min Price | $13.10 |
| Max Date | Sep-30-2021 |
| Max Price | $384.86 |
| Total Return | 629.34% |
| Annualized Return | 44.31% |
| Current Value of $1,000 Purchase | $7,293 |
| Number Returns | 2,080 |
| Average Return | 272.78% |
| Number Profitable Returns | 1,355 |
| Percent Profitable Returns | 65.14% |
| Number Unprofitable Returns | 725 |
| Percent Unprofitable Returns | 34.86% |
| Profitable to Unprofitable Returns Ratio | 1.87 |
| MRNA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $46,398,865,000 |
| Beta | 1.586 | Price to Sales | 5.88 |
| Earnings per Share | $-15.6000 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 2.907 |
| PRICE DATA | |
| 52 Week High | $142.79 |
| 52 Week Low | $62.55 |
| Analyst Target Price | $137.36 |
| 50-Day Moving Average | $105.9 |
| 200-Day Moving Average | $98.4 |
| FINANCIAL DATA | |
| Revenue per Share | $13.53 |
| Revenue | $5,153,000,000 |
| Profit Margin | -115.8% |
| Return on Equity | -37.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
MRNA Compare Returns with S&P 500
MRNA Trendline Chart
MRNA Moving Average Chart
MRNA Stock Return Map - See Patterns of Gains and Losses
MRNA Stock Returns/Purchase Dates